Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy

NCT02608528 · clinicaltrials.gov ↗

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Poor Accrual

Conditions

Non-Small Cell Lung Cancer (NSCLC)

Interventions

RADIATION: [18F]fluoroglucose(FDG)

Sponsor

Abramson Cancer Center at Penn Medicine